Galectin Therapeutics
GALT
GALT
60 hedge funds and large institutions have $17.4M invested in Galectin Therapeutics in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more ownership
Funds ownership: 12.22% → 15.22% (+3%)
0% more funds holding
Funds holding: 60 → 60 (0)
Holders
60
Holding in Top 10
–
Calls
$63K
Puts
$20K
Top Buyers
| 1 | +$3.53M | |
| 2 | +$66.6K | |
| 3 | +$35.8K | |
| 4 |
RGF
Retirement Guys Formula
Maumee,
Ohio
|
+$22.1K |
| 5 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$21.7K |
Top Sellers
| 1 | -$85.1K | |
| 2 | -$68.7K | |
| 3 | -$64.6K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$22.8K |
| 5 |
Neuberger Berman Group
New York
|
-$16.7K |